Alginic acid has anti-anaphylactic effects and inhibits inflammatory cytokine expression via suppression of nuclear factor-κB activation

被引:77
作者
Jeong, H. -J.
Lee, S. -A.
Moon, P. -D.
Na, H. -J.
Park, R. -K.
Um, J. -Y.
Kim, H. -M.
Hong, S. -H. [1 ]
机构
[1] Wonkwang Univ, VestibuloCochlear Res Ctr, Coll Pharm, Jeonbuk 570749, South Korea
[2] Kyung Hee Univ, Dept Pharmacol, Coll Oriental Med, Seoul, South Korea
[3] Woosuk Univ, Coll Pharm, Jeonbuk, South Korea
[4] Wonkwang Univ, VestibuloCochlear Res Ctr, Dept Microbiol & Immunol, Jeonbuk, South Korea
关键词
alginic acid; allergy; cytokines; histamine; mast cells; NF-kappa B;
D O I
10.1111/j.1365-2222.2006.02508.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 [免疫学];
摘要
Background Alginic acid is comprised of complex polymerized polysaccharides, and can be chemically extracted from seaweed. Alginic acid has an inhibitory effect on histamine release, but its molecular mechanisms are not well understood. Objective To investigate the effect of alginic acid on the mast cell-mediated anaphylactic and inflammatory reaction using in vivo and in vitro models and elucidate its molecular mechanisms. Materials and methods The effect of alginic acid on an allergy model was analysed by anaphylaxis, a histidine decarboxylase (HDC) assay, and a histamine assay. Cytokine production was analysed by means of ELISA. Cytokine expression was analysed by means of RT-PCR, and Western blotting. Transcription factor activity was analysed by a luciferase assay and a transcription factor-enzyme linked immunoassay. Results Alginic acid dose dependently inhibited compound 48/80-induced systemic anaphylaxis with doses of 0.25-1 g/kg 1 h (P < 0.01, n=6) and significantly inhibited passive cutaneous anaphylaxis by 54.8%. Alginic acid (0.01-1 mu g/mL) inhibited histamine release from serum and peritoneal mast cells (P < 0.01). All these effects were stronger than those of disodium cromoglycate (DSCG), the reference drug tested. Alginic acid also inhibited HDC expression and activity on the phorbol myristate acetate (PMA)+A23187-stimulated human mast cell line, HMC-1 cells. Moreover, alginic acid significantly inhibited the production of PMA+A23187-induced inflammatory cytokines, IL-1 beta and TNF-alpha, but not that of IL-6 or IL-8. In activated HMC-1 cells, the expression level of nuclear factor (NF)-kappa B/Rel A protein increased in the nucleus, whereas the level of NF-kappa B/Rel A in the nucleus was decreased by alginic acid treatment. In addition, alginic acid (0.01 mu g/mL) decreased the PMA+A23187-induced luciferase activity and DNA-binding activity. Conclusion The present results indicate that alginic acid has potent anti-anaphylactic and anti-inflammatory properties.
引用
收藏
页码:785 / 794
页数:10
相关论文
共 29 条
[1]
Inhibitory effect of alginic acids on hyaluronidase and on histamine release from mast cells [J].
Asada, M ;
Sugie, M ;
Inoue, M ;
Nakagomi, K ;
Hongo, S ;
Murata, K ;
Irie, S ;
Takeuchi, T ;
Tomizuka, N ;
Oka, S .
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1997, 61 (06) :1030-1032
[2]
BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
[3]
TUMOR-NECROSIS-FACTOR AND INTERLEUKIN-1 LEAD TO PHOSPHORYLATION AND LOSS OF I-KAPPA-B-ALPHA - A MECHANISM FOR NF-KAPPA-B ACTIVATION [J].
BEG, AA ;
FINCO, TS ;
NANTERMET, PV ;
BALDWIN, AS .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (06) :3301-3310
[4]
BRADDING P, 1993, J IMMUNOL, V151, P3853
[5]
Cytokines in neuroinflammation and Alzheimer's disease [J].
Cacquevel, M ;
Lebeurrier, N ;
Chéenne, S ;
Vivien, D .
CURRENT DRUG TARGETS, 2004, 5 (06) :529-534
[6]
REGULATION OF TUMOR NECROSIS FACTOR-ALPHA TRANSCRIPTION IN MACROPHAGES - INVOLVEMENT OF 4 KAPPA-B-LIKE MOTIFS AND OF CONSTITUTIVE AND INDUCIBLE FORMS OF NF-KAPPA-B [J].
COLLART, MA ;
BAEUERLE, P ;
VASSALLI, P .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (04) :1498-1506
[7]
Cook E. B., 2002, Current Drug Targets - Inflammation and Allergy, V1, P167, DOI 10.2174/1568010023344733
[8]
Fiorini E, 2000, Dev Immunol, V7, P195, DOI 10.1155/2000/48239
[9]
Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens [J].
Galien, R ;
Evans, HF ;
Garcia, T .
MOLECULAR ENDOCRINOLOGY, 1996, 10 (06) :713-722
[10]
GALLI SJ, 1994, ADV IMMUNOL, V55, P1